期刊文献+

sIL-33联合CEA、CA19-9检测对结直肠癌的诊断价值 被引量:5

Diagnostic value of the detection of sIL-33 combined with CEA and CA19-9 in colorectal cancer
下载PDF
导出
摘要 目的研究结直肠癌(CRC)患者血清白介素-33(s IL-33)水平,评价其对CRC诊断的临床意义。方法收集121例CRC患者的术前血清标本与临床病理资料,以81例体检健康者、33例肠息肉患者作为对照。用ELISA法检测s IL-33含量,分析其与临床病理参数的关系,并采用ROC曲线、Logistic回归分析比较s IL-33、CEA和CA19-9单独检测或3者联合检测的诊断价值。结果 CRC患者s IL-33含量[172.44(108.08,321.57)pg/m L]显著高于肠息肉组[67.31(37.72,130.44)pg/m L]和体检健康组[71.73(36.80,85.53)pg/m L],差异有统计学意义(P均<0.01)。s IL-33与CRC的分化程度、肿瘤部位有关,差异有统计学意义(P均<0.01)。s IL-33、癌胚抗原(CEA)和糖链抗原19-9(CA19-9)3者联合检测的敏感性(80.99%)、准确率(86.38%)和曲线下面积AUCROC(0.933 4)均比单独检测高,其特异性(92.11%)也处于较高水平,具有较好的诊断价值。结论s IL-33、CEA和CA19-9 3者联合检测对CRC诊断具有较好的临床应用价值,可作为潜在的血清学标志物。 Objective To investigate the level of serum interleukin-33( s IL-33) in colorectal carcinoma( CRC) patients and its clinical significance. Methods The preoperative serum samples and clinical pathological data from 121 CRC patients were collected,and81 healthy persons and 33 patients with intestinal polyp were selected as the control. The s IL-33 level was detected using an ELISA method,and its correlation with clinical pathological features was analyzed. The diagnostic values of the detection of s IL-33,CEA and CA19-9 alone or their combination in CRC were investigated by ROC curve and Logistic regression analysis. Results The s IL-33 levels [median( P25,P75) ]in CRC patients [172. 44( 108. 08,321. 57) pg / m L]were significantly higher than those in intestinal polyp patients [67. 31( 37. 72,130. 44) pg / m L]and healthy controls [71. 73( 36. 80,85. 53) pg / m L]( P〈 0. 01). The s IL-33 levels in CRC patients were significantly correlated with the differentiated grade and location of the tumor( P 〈0. 01). The sensitivity( 80.99%),accuracy( 86. 38%) and AUCROC( 0. 933 4) of the combined detection of s IL-33,CEA and CA19-9 were higher than that of their single detection,and its specificity( 92. 11%) was also in a high level,so it had preferable diagnostic value in CRC. Conclusion The combined detection of s IL-33,CEA and CA19-9,as a new potential serum marker,has preferable value in the diagnosis of CRC.
出处 《临床检验杂志》 CAS CSCD 2015年第8期596-598,共3页 Chinese Journal of Clinical Laboratory Science
基金 国家自然科学基金(81171653) 海外及港澳学者合作研究基金(31428005) 江苏省条件建设与民生科技专项资金项目(BL2014034)
关键词 白细胞介素-33 结直肠癌 诊断价值 interleukin-33 colorectal carcinoma diagnostic value
  • 相关文献

参考文献9

  • 1Wang S, Ding L, Liu SS, et al. IL-33 : a potential therapeutic target in autoimmune diseases[J]. J Investig Med, 2012, 60(8) :1151-1156.
  • 2Schmieder A, Muhhoff G, Radons J. Interleukin-33 acts as a pro-in- flammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma ceils [J]. Cytokine, 2012, 60(2) :514-521.
  • 3Sun P, Ben Q, Tu S, et al. Serum interleukin-33 levels in patients with gastric cancer[J]. Dig Dis Sci, 2011, 56(12) :3596-3601.
  • 4Zhang P, Liu XK, Chu Z, et al. Detection of interleukin-33 in ser- um and carcinoma tissue from patients with hepatocellular carcinoma and its clinical implications [J l. J Int Med Res, 2012, 40 (5): 1654-1661.
  • 5Milovanovic M, Volarevic V, Radosavljevic G, et al. IL-33/ST2 ax- is in inflammation and immunopathology [J]. Immunol Res, 2012, 52(1-2) :89-99.
  • 6文雯,吕全省,李刚,高鑫,张学光,蒋敬庭,王雪峰,朱一蓓,卢斌峰.基因转染表达小鼠白细胞介素-33及其抗肿瘤机制研究[J].中华实验外科杂志,2015,32(1):60-62. 被引量:3
  • 7Hu LA, Fu Y, Zhang DN, et al. Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer [J]. Asian Pac J Cancer Prey, 2013, 14(4) :2563-2566.
  • 8吴传勇,薛剑,徐淑君,梁小卉,娄加陶.流式荧光法检测CEA、CYFRA21-1和NSE的应用评价[J].临床检验杂志,2014,32(2):95-97. 被引量:6
  • 9Cai WK, Lin JJ, He GH, et al. Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocar- cinoma[J]. Int J Clin Exp Pathol, 2014, 7(11) :7890-7898.

二级参考文献12

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics 2009 [ J ]. CA Cancer J Clin, 2009, 59(4) : 225-249.
  • 2Sato M, Shames DS, Gazdar AF, et al. A translational view of the molecular pathogenesis of lung cancer[ J]. J Thorae Oncol, 2007, 2 (4) : 327-343.
  • 3EP5-A2. Evaluation of precision performance of quantitative measure- ment procedures; approved guideline-second edition [ S ].
  • 4Tomita M, Shimizu T, Ayabe T, et al. Carcinoembryanic antigen level in serum and pleural lavage fluid in non-small cell lung cancer [J]. Thorac Cardiovasc Surg, 2010, 58(6) : 350-353.
  • 5Ardizzoni A, Cafferata MA, Tiseo M, et al. Decline in serum earci- noembryonic antigen and cytokeratin 19 fragment during chemothera- py predicts objective response and survival in patients with advancednon small cell lung cancer [ J ]. Cancer, 2006, 107 ( 12 ) : 2842- 2849.
  • 6Scott A, Salgia R. Biomarkers in lung cancer: from early detection to novel therapeutics and decision making[ J]. Biomark Med, 2008, 2 (6) : 577-586. W.
  • 7aterboer T, Sehr P, Pawlita M. Suppression of non-specific bind- ing in serological Luminex assays[ J]. J Immunol Methods ,2006,309 (1-2) : 200-204.
  • 8Galon J,Costes A,Sanchez-Cabo F,et al.Type,density,and location of immune cells within human colorectal tumors predict clinical outcome[J].Science,2006,313 (5795):1960-1964.
  • 9Zou W.Immunosuppressive networks in the tumour environment and their therapeutic relevance[J].Nat Rev Cancer,2005,5 (4):263-274.
  • 10Espinassous Q,Garcia-de-Paco E,Garcia-Verdugo l,et al.IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex[J].J Immunol,2009,183 (2):1446-1455.

共引文献6

同被引文献59

  • 1高羽,张连阳,刘宝华,童卫东,张安平,陈金萍,徐琰.腹腔镜结直肠癌根治术后胃肠运动与血清胃肠激素的变化[J].第三军医大学学报,2006,28(6):598-600. 被引量:23
  • 2张明金,王仕琛,李业云,等.腹腔镜结肠直肠癌根治手术与传统根治手术疗效比较.中华普外科手术学杂志,2014,8:321-324.
  • 3Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014 [ J ] CA : a cancer journal for clinicians,2014,64 (2) : 104-117.
  • 4DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survi- vorship statistics,2014 [J]. CA : a cancer journal for clinicians,2014, 64(4) :252-271.
  • 5Tone LA, Bray F, Siegel RL, et al. Global cancer statistics,2012 [ J ]. CA:a cancer journal for clinicians,2015,65(2) :87-108.
  • 6Chen W. Cancer statistics:updated caneer burden in China[ J ]. Chi- nese journal of caneer research ,2015,27 ( 1 ) : 1.
  • 7Yuge R, Kitadai Y, Shinagawa K, et al. mTOR and PDGF pathway blockade inhibits liver metastasis of colorectal cancer by modulating the tumor microenvironment [ J ]. Am J Patho1,2015,185 ( 2 ) :399 -408.
  • 8Viana LR, Gomes-Marcondes MC. A leucine-rich diet modulates the tumor-induced down-regulation of the MAPK/ERK and PI3K/Akt/ roTOR signaling pathways and maintains the expression of the ubiquit- in-proteasome pathway in the placental tissue of NklRI mice[J]. Biol Reprod,2015,92 (2) :49.
  • 9E J,Xing J,Gong H,He J,et al. Combine MEK inhibition with PI3K/ roTOR inhibition exert inhibitory tumor ~owth effect on KRAS and PIK3CA mutation CRC xenografts due to reduced expression of VEGF and matrix metallopeptidase-9 [ J ]. Tumour Biol, 2015, 36 ( 2 ) : 1091-1097.
  • 10Sperling J, Ziemann C, Gittler A, et al. Tumour growth of colorectal rat liver metastases is inhibited by hepatic arterial infusion of the roTOR-inhibitor temsirolimus after portal branch ligation [ J ]. Clin Exp Metastasis, 2015,32 ( 4 ) : 313-321.

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部